arrow
M

Michael S. Middleton

johannes gutenberg university of mainz
H指数:53
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative Precision of 3D MRE and 2D MRE for Measurement of Liver Stiffness in Adults with Severe Obesity

3D MRE与2D MRE测量严重肥胖成人肝脏硬度的比较精度

Radiology
IF15.2
2026-05-011
PRE
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes

全球MASLD纵向评估磁共振弹性成像(GOLDMINE)研究:一项关于MASLD临床结局中影像生物标志物的多中心、国际前瞻性队列研究

2026-04-012
PRE
Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis
2023-02-0121
OAAI
Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study
RADIOLOGY
IF15.2
2021-03-0158
OA
Temperature-corrected proton density fat fraction estimation using chemical shift-encoded MRI in phantoms

在体模中使用化学位移编码的MRI估算温度校正的质子密度脂肪分数

2021-02-0915
OAAI
Cilofexor, a NonsteroidalFXRAgonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

Cilofexor,一种非类固醇醛酮受体激动剂,用于非肝硬化NASH患者: 一项2期随机对照试验

2020-07-14245
PREAI
Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys A Randomized Clinical Trial
2019-01-22174
OAAI
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib
2019-01-01153
OAAI
Acetyl-CoA carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
2018-12-01168
PREAI